613 related articles for article (PubMed ID: 34482088)
1. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy.
Niu B; Liao K; Zhou Y; Wen T; Quan G; Pan X; Wu C
Biomaterials; 2021 Oct; 277():121110. PubMed ID: 34482088
[TBL] [Abstract][Full Text] [Related]
2. Engineering nanomedicine for glutathione depletion-augmented cancer therapy.
Xiong Y; Xiao C; Li Z; Yang X
Chem Soc Rev; 2021 May; 50(10):6013-6041. PubMed ID: 34027953
[TBL] [Abstract][Full Text] [Related]
3. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
4. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
5. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
[TBL] [Abstract][Full Text] [Related]
6. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
7. A Potent Strategy of Combinational Blow Toward Enhanced Cancer Chemo-Photodynamic Therapy via Sustainable GSH Elimination.
Yu J; Xiao H; Yang Z; Qiao C; Zhou B; Jia Q; Wang Z; Wang X; Zhang R; Yang Y; Wang Z; Li J
Small; 2022 Mar; 18(9):e2106100. PubMed ID: 34910845
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis.
Wan Y; Cao Y; Hu D; Lai Q; Liu Y; Chen Y; Wu M; Feng S
ACS Biomater Sci Eng; 2024 Jun; 10(6):3813-3824. PubMed ID: 38779799
[TBL] [Abstract][Full Text] [Related]
10. Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-Like Cancer Cell Death.
Nie T; Zou W; Meng Z; Wang L; Ying T; Cai X; Wu J; Zheng Y; Hu B
Adv Mater; 2022 Nov; 34(45):e2206286. PubMed ID: 36134532
[TBL] [Abstract][Full Text] [Related]
11. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
12. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
13. Hypertoxic self-assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis.
Gao Y; Li Y; Cao H; Jia H; Wang D; Ren C; Wang Z; Yang C; Liu J
J Nanobiotechnology; 2022 Aug; 20(1):390. PubMed ID: 36045424
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for combined photo- and chemo-dynamic therapy of cancer cells involving endogenous glutathione depletion.
Mittal A; Yadav M; Biswas L; Verma AK; Roy I
Nanomedicine (Lond); 2023 Apr; 18(8):679-694. PubMed ID: 37264976
[TBL] [Abstract][Full Text] [Related]
15. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
[TBL] [Abstract][Full Text] [Related]
16. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells.
Sun Y; Zheng Y; Wang C; Liu Y
Cell Death Dis; 2018 Jul; 9(7):753. PubMed ID: 29988039
[TBL] [Abstract][Full Text] [Related]
18. Fe(III)-Naphthazarin Metal-Phenolic Networks for Glutathione-Depleting Enhanced Ferroptosis-Apoptosis Combined Cancer Therapy.
Liu Z; Liu S; Liu B; Bian Y; Yuan M; Yang C; Meng Q; Chen C; Ma P; Lin J
Small; 2023 May; 19(19):e2207825. PubMed ID: 36772903
[TBL] [Abstract][Full Text] [Related]
19. Self-engineered binary nanoassembly enabling closed-loop glutathione depletion-amplified tumor ferroptosis.
Lei J; Zhang S; Wu Z; Sun X; Zhou B; Huang P; Fang M; Li L; Luo C; He Z
Biomater Sci; 2023 Nov; 11(22):7373-7386. PubMed ID: 37791561
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of ultralow-intensity NIR light-triggered photodynamic therapy based on exo- and endogenous synergistic effects through combined glutathione-depletion chemotherapy.
Shi JH; Wang TR; You YQ; Akhtar ML; Liu ZJ; Han F; Li Y; Wang Y
Nanoscale; 2019 Jul; 11(27):13078-13088. PubMed ID: 31265049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
